相似文献
1
Increasing resistance of enterococci to ciprofloxacin.
Antimicrob Agents Chemother. 1992 Nov;36(11):2533-5. doi: 10.1128/AAC.36.11.2533.
2
Unorthodox antibiotic combinations including ciprofloxacin against high-level gentamicin resistant enterococci.
J Antimicrob Chemother. 1996 Apr;37(4):727-36. doi: 10.1093/jac/37.4.727.
3
Emergence of High-level Gentamicin Resistance among Clinical Isolates from Burn Patients in South-west of Iran: Vancomycin Still Working.
Pol J Microbiol. 2018;67(4):401-406. doi: 10.21307/pjm-2018-043.
4
The prevalence and clonal expansion of high-level gentamicin-resistant enterococci isolated from blood cultures in a Dutch university hospital.
J Antimicrob Chemother. 1999 Dec;44(6):795-8. doi: 10.1093/jac/44.6.795.
5
Ecological impact of ciprofloxacin on commensal enterococci in healthy volunteers.
J Antimicrob Chemother. 2017 Jun 1;72(6):1574-1580. doi: 10.1093/jac/dkx043.
6
Transferability and genetic relatedness of high-level gentamicin resistance among enterococci.
Antimicrob Agents Chemother. 1994 May;38(5):1194-6. doi: 10.1128/AAC.38.5.1194.
7
[Antibiotic Resistance of Enterococci Isolated from Healthy Humans and Patients with Various Pathologies.].
Antibiot Khimioter. 2016;61(7-8):27-32.
8
Comparison of in vitro inhibitory and bactericidal activities of daptomycin (LY 146032) and four reference antibiotics, singly and in combination, against gentamicin-susceptible and high-level-gentamicin-resistant enterococci.
Chemotherapy. 1993 Sep-Oct;39(5):302-9. doi: 10.1159/000239141.
9
In vitro activity of the combination of trovafloxacin and other antibiotics against enterococci.
Diagn Microbiol Infect Dis. 1997 Dec;29(4):233-9. doi: 10.1016/s0732-8893(97)00161-2.
10
Increasing prevalence of high-level gentamicin resistance among Enterococci isolated in Greece.
Chemotherapy. 2001 Mar-Apr;47(2):86-9. doi: 10.1159/000048505.
引用本文的文献
1
Investigating antimicrobial-resistant bacteria from exotic domestic birds - a One Health concern.
Braz J Vet Med. 2024 Aug 3;46:e001624. doi: 10.29374/2527-2179.bjvm001624. eCollection 2024.
2
Prevalence of virulence and resistance to antibiotics in pathogenic enterococci isolated from mastitic cows.
J Vet Med Sci. 2016 Dec 1;78(11):1663-1668. doi: 10.1292/jvms.15-0718. Epub 2016 Aug 1.
3
Development of fluoroquinolone resistance in Enterococcus faecalis and role of mutations in the DNA gyrase gyrA gene.
Antimicrob Agents Chemother. 1996 Nov;40(11):2558-61. doi: 10.1128/AAC.40.11.2558.
4
Survey of enterococcal susceptibility patterns in Belgium.
J Clin Microbiol. 1996 Oct;34(10):2572-6. doi: 10.1128/jcm.34.10.2572-2576.1996.
5
Ciprofloxacin. An updated review of its pharmacology, therapeutic efficacy and tolerability.
Drugs. 1996 Jun;51(6):1019-74. doi: 10.2165/00003495-199651060-00010.
6
Current perspectives on glycopeptide resistance.
Clin Microbiol Rev. 1995 Oct;8(4):585-615. doi: 10.1128/CMR.8.4.585.
7
Epidemiology of quinolone resistance: Europe and North and South America.
Drugs. 1995;49 Suppl 2:36-42. doi: 10.2165/00003495-199500492-00007.
8
In vitro and in vivo activities of clinafloxacin, CI-990 (PD 131112), and PD 138312 versus enterococci.
Antimicrob Agents Chemother. 1995 Sep;39(9):2123-7. doi: 10.1128/AAC.39.9.2123.
9
Bactericidal activity of the fluoroquinolone WIN 57273 against high-level gentamicin-resistant Enterococcus faecalis.
Antimicrob Agents Chemother. 1993 Nov;37(11):2470-3. doi: 10.1128/AAC.37.11.2470.
10
In vitro activities of BAY Y3118, ciprofloxacin, ofloxacin, and fleroxacin against gram-positive and gram-negative pathogens from respiratory tract and soft tissue infections.
Antimicrob Agents Chemother. 1993 Sep;37(9):2017-9. doi: 10.1128/AAC.37.9.2017.
本文引用的文献
1
High-level aminoglycoside-resistant enterococci. Colonization of nursing home and acute care hospital patients.
Arch Intern Med. 1987 Sep;147(9):1591-4. doi: 10.1001/archinte.147.9.1591.
2
In vitro activity of ciprofloxacin against gram-positive bacteria. An overview.
Am J Med. 1987 Apr 27;82(4A):33-9.
3
Enterococcal superinfection in patients treated with ciprofloxacin.
J Antimicrob Chemother. 1988 Jan;21(1):113-5. doi: 10.1093/jac/21.1.113.
4
Development of resistance in Pseudomonas aeruginosa to imipenem, norfloxacin, and ciprofloxacin during therapy: proof provided by typing with a DNA probe.
J Infect Dis. 1988 Apr;157(4):743-8. doi: 10.1093/infdis/157.4.743.
5
Identification of Streptococcus faecalis and Streptococcus faecium and susceptibility studies with newly developed antimicrobial agents.
J Clin Microbiol. 1987 May;25(5):787-90. doi: 10.1128/jcm.25.5.787-790.1987.
6
Nosocomial infection by gentamicin-resistant Streptococcus faecalis. An epidemiologic study.
Ann Intern Med. 1987 May;106(5):687-91. doi: 10.7326/0003-4819-106-5-687.
7
High-level resistance to gentamicin in Streptococcus faecalis: risk factors and evidence for exogenous acquisition of infection.
J Infect Dis. 1986 Jun;153(6):1075-83. doi: 10.1093/infdis/153.6.1075.
8
High-level penicillin resistance among isolates of enterococci. Implications for treatment of enterococcal infections.
Ann Intern Med. 1989 Apr 1;110(7):515-20. doi: 10.7326/0003-4819-110-7-515.
9
Enterococci highly resistant to penicillin and ampicillin: an emerging clinical problem?
J Clin Microbiol. 1989 Sep;27(9):2091-5. doi: 10.1128/jcm.27.9.2091-2095.1989.
10
In vitro activities of quinolones against enterococci resistant to penicillin-aminoglycoside synergy.
Antimicrob Agents Chemother. 1989 Jan;33(1):71-7. doi: 10.1128/AAC.33.1.71.
Zotero 插件